These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 37524129)

  • 1. Efficacy and safety of NAHAO® hydrogel in amelioration of chemoradiotherapy-induced oral mucositis: An preliminary clinical study (ChiCTR2200064766).
    Zhang Y; Mao R; Liu Z; Shi M; Song D; Liu X; Yan D; Bao J; Tang Y
    J Stomatol Oral Maxillofac Surg; 2023 Dec; 124(6S):101568. PubMed ID: 37524129
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sprayable NAHAO® hydrogel alleviates pain and accelerates rat oral mucositis wound healing.
    Zhao Y; Mao R; Yan H; Zhang Y; Ma H; Tang Y
    J Stomatol Oral Maxillofac Surg; 2023 Feb; 124(1S):101301. PubMed ID: 36182076
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of a spray compound containing a pool of collagen precursor synthetic aminoacids (l-proline, l-leucine, l-lysine and glycine) combined with sodium hyaluronate to manage chemo/radiotherapy-induced oral mucositis: preliminary data of an open trial.
    Colella G; Cannavale R; Vicidomini A; Rinaldi G; Compilato D; Campisi G
    Int J Immunopathol Pharmacol; 2010; 23(1):143-51. PubMed ID: 20378002
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of an Indomethacin Oral Spray on Pain Due to Oral Mucositis in Cancer Patients Treated With Radiotherapy and Chemotherapy: A Double-Blind, Randomized, Placebo-Controlled Trial (JORTC-PAL04).
    Nagaoka H; Momo K; Hamano J; Miyaji T; Oyamada S; Kawaguchi T; Homma M; Yamaguchi T; Morita T; Kizawa Y
    J Pain Symptom Manage; 2021 Sep; 62(3):537-544. PubMed ID: 33516927
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SAMITAL® improves chemo/radiotherapy-induced oral mucositis in patients with head and neck cancer: results of a randomized, placebo-controlled, single-blind Phase II study.
    Pawar D; Neve RS; Kalgane S; Riva A; Bombardelli E; Ronchi M; Petrangolini G; Morazzoni P
    Support Care Cancer; 2013 Mar; 21(3):827-34. PubMed ID: 22945882
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phase II, randomized, double-blind, placebo-controlled study of recombinant human intestinal trefoil factor oral spray for prevention of oral mucositis in patients with colorectal cancer who are receiving fluorouracil-based chemotherapy.
    Peterson DE; Barker NP; Akhmadullina LI; Rodionova I; Sherman NZ; Davidenko IS; Rakovskaya GN; Gotovkin EA; Shinkarev SA; Kopp MV; Kulikov EP; Moiseyenko VM; Gertner JM; Firsov I; Tuleneva T; Yarosh A; Woon CW
    J Clin Oncol; 2009 Sep; 27(26):4333-8. PubMed ID: 19636011
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effects of a combination oral spray (Mucosamin®) for the prevention of oral mucositis in pediatric patients undergoing hematopoietic stem cell transplantation: a double blind randomized clinical trial.
    Shahrabi M; Solduzian M; Babaie MH; Mousavi SA; Goodarzi N; Ravari NS; Sadeghi K
    Support Care Cancer; 2022 Oct; 30(10):7963-7972. PubMed ID: 35732749
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Distinct TRPV1- and TRPA1-based mechanisms underlying enhancement of oral ulcerative mucositis-induced pain by 5-fluorouracil.
    Yamaguchi K; Ono K; Hitomi S; Ito M; Nodai T; Goto T; Harano N; Watanabe S; Inoue H; Miyano K; Uezono Y; Matoba M; Inenaga K
    Pain; 2016 May; 157(5):1004-1020. PubMed ID: 26808144
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy and safety of thalidomide in preventing oral mucositis in patients with nasopharyngeal carcinoma undergoing concurrent chemoradiotherapy: A multicenter, open-label, randomized controlled trial.
    Liang L; Liu Z; Zhu H; Wang H; Wei Y; Ning X; Shi Z; Jiang L; Lin Z; Yan H; Wang R; Hu K
    Cancer; 2022 Apr; 128(7):1467-1474. PubMed ID: 34910297
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Confounding factors associated with oral mucositis assessment in patients receiving chemoradiotherapy for head and neck cancer.
    Chung YL; Pui NNM
    Support Care Cancer; 2017 Sep; 25(9):2743-2751. PubMed ID: 28353040
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prophylaxis of Oral Mucositis with Iodine Solution during Concurrent Chemoradiation of Head and Neck Cancer: Preliminary Results of a Double-Blind, Randomized Controlled Trial.
    Namuangchan Y; Chailertwanich O; Susinsamphan S; Supakalin N; Supaadirek C; Krusun S; Pesee M; Thamronganantasakul K
    Asian Pac J Cancer Prev; 2023 Jul; 24(7):2445-2454. PubMed ID: 37505779
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of polyacrylate silver salt/polyvinylpyrrolidone-based liquid oral gel in management of concurrence chemoradiotherapy-induced oral mucositis.
    Chin HL; Chung KP; Liu HC; Chen RS; Chang HH; Chen MH
    J Formos Med Assoc; 2023 Aug; 122(8):723-730. PubMed ID: 36623972
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of an oral mucosa protective formulation on chemotherapy- and/or radiotherapy-induced oral mucositis: a prospective study.
    Ueno T; Yatsuoka W; Ishiki H; Miyano K; Uezono Y
    BMC Cancer; 2022 Jan; 22(1):90. PubMed ID: 35062896
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Severe oral mucositis relating to pain and worse oral condition among patients with solid tumors undergoing treatment with FOLFIRI and 5-FU: a retrospective study.
    Almeida LC; Orcina BDF; Maciel AP; Santos DD; Manzano BR; Santos PSDS
    Sao Paulo Med J; 2022; 140(4):588-594. PubMed ID: 35946677
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A phase II study of HMB/Arg/Gln against oral mucositis induced by chemoradiotherapy for patients with head and neck cancer.
    Yokota T; Hamauchi S; Yoshida Y; Yurikusa T; Suzuki M; Yamashita A; Ogawa H; Onoe T; Mori K; Onitsuka T
    Support Care Cancer; 2018 Sep; 26(9):3241-3248. PubMed ID: 29627862
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy and safety of transdermal fentanyl for the treatment of oral mucositis pain caused by chemoradiotherapy in patients with esophageal squamous cell carcinoma.
    Xing SZ; Zhang Y
    Support Care Cancer; 2015 Mar; 23(3):753-9. PubMed ID: 25179692
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analgesic Mechanisms of Steroid Ointment against Oral Ulcerative Mucositis in a Rat Model.
    Naniwa M; Nakatomi C; Hitomi S; Matsuda K; Tabuchi T; Sugiyama D; Kubo S; Miyamura Y; Yoshino K; Akifusa S; Ono K
    Int J Mol Sci; 2021 Nov; 22(22):. PubMed ID: 34830488
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Mouse Model for Oral Mucositis Induced by Cancer Chemotherapy.
    Shimamura Y; Takeuchi I; Terada H; Makino K
    Anticancer Res; 2018 Jan; 38(1):307-312. PubMed ID: 29277788
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phenylbutyrate mouthwash mitigates oral mucositis during radiotherapy or chemoradiotherapy in patients with head-and-neck cancer.
    Yen SH; Wang LW; Lin YH; Jen YM; Chung YL
    Int J Radiat Oncol Biol Phys; 2012 Mar; 82(4):1463-70. PubMed ID: 21840136
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of symptomatic oral mucositis with sodium hyaluronate and synthetic amino acid precursors of collagen in patients undergoing haematopoietic stem cell transplantation.
    Ruggiero T; Pol R; Camisassa D; Simiele S; Giaccone L; Carossa S
    J Biol Regul Homeost Agents; 2018; 32(3):737-743. PubMed ID: 29921408
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.